Observational studyUpdates in surgery2026
Perineal infection and risk factors following extralevator abdominoperineal excision and reconstruction with an absorbable synthetic prosthesis.
Observational study in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extralevator abdominoperineal excision (ELAPE) improves surgical margins in distal rectal cancer compared to conventional amputation; however, it is associated with higher rates of perineal morbidity. This study aimed to evaluate the incidence of perineal infections and identify associated risk factors in patients with rectal adenocarcinoma undergoing ELAPE with perineal reconstruction using an absorbable synthetic prosthesis. This prospective observational study including consecutive patients treated between 2009 and 2024. All patients underwent standardized perineal reconstruction with an absorbable synthetic prosthesis. Clinical, tumor, surgical, and postoperative complication variables were recorded. Univariate and multivariate analyses were performed to identify factors associated with perineal infection. A total of 61 patients were analyzed. Perineal infection occurred in 23%, with most infections developing within the first 30 postoperative days. Multivariate analysis identified obesity (Odds Ratio [OR] 74.3), active smoking (OR 33.7), and circumferential margin involvement observed on basal magnetic resonance imaging (OR 28) as independent risk factors. Patients with perineal infection had longer hospital stays, more readmissions, more postoperative visits, and higher complications severity. Infection was not associated with an increased rate of perineal hernia, which was low in our cohort (3%). In conclusion, perineal reconstruction with an absorbable synthetic prosthesis following ELAPE is safe and effective. Identification of patients at high risk for perineal infection enables targeted preventive strategies and informs future comparative studies of perineal reconstruction techniques.
Indexed as
Identifiers
41419725What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.